Ani Pharmaceuticals (ANIP) Long-Term Deferred Tax (2014 - 2026)
Ani Pharmaceuticals (ANIP) posted Long-Term Deferred Tax of $66.6 million for Q1 2026, down 3.64% sequentially from $69.1 million in Q4 2025, and down 24.79% YoY from $88.5 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Long-Term Deferred Tax for 13 years, with the latest figure at $66.6 million in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 24.79% year-over-year to $66.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.6 million (down 24.79% YoY) and the FY2025 annual result came in at $69.1 million, down 18.84% from the prior year.
- Long-Term Deferred Tax eased to $66.6 million in Q1 2026 per ANIP's latest filing, from $69.1 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $92.0 million in Q2 2025 and troughed at $66.6 million in Q1 2026.
- A 5-year average of $80.2 million and a median of $81.4 million in 2022 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2026: Long-Term Deferred Tax soared 41.4% in 2022, then slipped 24.79% in 2026.
- Over 5 years, Long-Term Deferred Tax stood at $81.4 million in 2022, then increased by 11.49% to $90.7 million in 2023, then fell by 6.18% to $85.1 million in 2024, then declined by 18.84% to $69.1 million in 2025, then retreated by 3.64% to $66.6 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $66.6 million, $69.1 million, and $71.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.50 Mn |
| Mar 31, 2026 | 66.56 Mn |
| Dec 31, 2025 | 69.07 Mn |
| Sep 30, 2025 | 71.40 Mn |
| Jun 30, 2025 | 92.03 Mn |
| Mar 31, 2025 | 88.49 Mn |
| Dec 31, 2024 | 85.11 Mn |
| Sep 30, 2024 | 67.66 Mn |
| Jun 30, 2024 | 89.51 Mn |
| Mar 31, 2024 | 87.61 Mn |
| Dec 31, 2023 | 90.71 Mn |
| Sep 30, 2023 | 84.39 Mn |
| Jun 30, 2023 | 81.50 Mn |
| Mar 31, 2023 | 80.96 Mn |
| Dec 31, 2022 | 81.36 Mn |
| Sep 30, 2022 | 77.34 Mn |
| Jun 30, 2022 | 76.59 Mn |
| Mar 31, 2022 | 73.54 Mn |
| Dec 31, 2021 | 67.94 Mn |
| Sep 30, 2021 | 60.20 Mn |